BIONIK LABORATORIES CORP. Accounts Receivable, Credit Loss Expense (Reversal)

BIONIK LABORATORIES CORP. Accounts Receivable, Credit Loss Expense (Reversal)

BIONIK LABORATORIES CORP. reported Accounts Receivable, Credit Loss Expense (Reversal) of $0 for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-21.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ProvisionForDoubtfulAccounts · last filed 2023-06-21

• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for the quarter ending 2021-03-31 was $0.00.
• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for the quarter ending 2020-03-31 was $0.00.
• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for the quarter ending 2019-12-31 was $167.50K, a 1994.80% increase year-over-year.
• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for fiscal 2023 was $0.00.
• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for fiscal 2022 was $0.00.
• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
• BIONIK LABORATORIES CORP. accounts receivable, credit loss expense (reversal) for fiscal 2020 was $167.50K.